Evidence map›Paper›PMID 42568130›Full record

SynthesisAmerican journal of human biology : the official journal of the Human Biology Council2026

Second-To-Fourth Digit Ratio (2D:4D) in Breast Cancer: A Systematic Review.

Abdullah Avcı, Emine Kaplan Serin

Abstract readSystematic Review
In one paragraph

Synthesis in American journal of human biology : the official journal of the Human Biology Council, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Abdullah AvcıAnesthesia Program, Vocational School of Health Services, Toros University, Mersin, Turkey.ORCID https://orcid.org/0000-0002-3696-8414
Emine Kaplan SerinDepartment of Medical Nursing, Faculty of Nursing, Mersin University, Mersin, Turkey.ORCID https://orcid.org/0000-0002-7327-9167

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe second-to-fourth digit ratio (2D:4D) is considered an indirect marker of prenatal sex hormone exposure and has been investigated as a potential indicator of susceptibility to hormone-related diseases, including breast cancer. The purpose of this systematic review is to evaluate the relationship between the 2D:4D finger ratio and breast cancer risk.

methodsThis systematic review was conducted in accordance with the PRISMA 2020 statement. PubMed, Scopus, and Web of Science were searched without publication year restrictions. Eligible observational studies were selected using predefined PICOS criteria, and methodological quality was assessed using Joanna Briggs Institute critical appraisal checklists.

resultsSeven observational studies involving 13 556 women (2817 breast cancer cases and 10 739 controls) were included. Most case-control studies reported significantly higher right- and/or left-hand 2D:4D ratios among women with breast cancer than among healthy controls. However, the prospective cohort study reported an association only for the left-hand 2D:4D ratio, whereas the largest multicenter case-control study did not demonstrate a consistent overall association between right- or left-hand 2D:4D ratios and breast cancer risk. Overall, current findings suggest a possible association between higher 2D:4D ratios and breast cancer risk, although substantial heterogeneity exists across studies.

conclusionThis systematic review suggests that the 2D:4D finger ratio may be associated with breast cancer risk. However, substantial heterogeneity across studies warrants cautious interpretation, and further large prospective studies are needed to clarify its potential role in breast cancer risk assessment.

Indexed as

Breast NeoplasmsDigit RatiosFingersFemaleHumans2D:4Dbreast cancerdigit ratio

Identifiers

PMID42568130
PMCPMC13451560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.